Bloomberg journalist Sam Fazeli provides the list of reasons to trust Russian vaccine Sputnik V. These reasons are:
Russia with this vaccine is fifth on the list of vaccine makers with the most doses under contract through pre-purchase agreements;
Sputnik V has been tested in a phase III trial;
Efficacy at each interim analysis in the Sputnik V trial was consistently at 90% or above;
Sputnik V was developed using the kind of advanced vaccine technology employed in shots made by the AstraZeneca-Oxford University.
The journalist made evidence that the Sputnik V vaccine may well be as strong a candidate as the ones created in Western labs. He also stated that he would opt for a ride on Sputnik rather than a trip to CoronaVac’s golden stars.